David CateManufacturing Technical Specialist, Global Biologics Manufacturing Sciences and Technology (MSAT) at Genentech, a member of the Roche Group
David Cate has 25 years in the pharmaceutical industry spanning Biologics Drug Substance and Drug Product Manufacturing Operations, Gene Therapy Process Development and Manufacturing, Quality Operations and Systems, and Manufacturing Sciences and Technology. David joined Roche in 2003 and is currently supporting Roche's global pharma manufacturing network with the implementation of new innovative technologies across Biologics and Small Molecules. In his previous roles, he has lead the scale up of monoclonal antibody processes for commercial production, technology transfers of commercial biologics to contract manufacturing organizations, DS and DP manufacturing of IMP antibody drug conjugate production, and scale up of AAV vector production for gene therapy application. David earned a Bachelor of Science in Chemistry from University of California, Berkeley.